Corient Capital Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.02M | Buy |
4,188
+62
| +2% | +$29.9K | 0.15% | 121 |
|
|
2022
Q2 | $1.99M | Buy |
4,126
+702
| +21% | +$339K | 0.15% | 132 |
|
|
2022
Q1 | $1.68M | Buy |
3,424
+557
| +19% | +$274K | 0.11% | 167 |
|
|
2021
Q4 | $1.33M | Buy |
2,867
+144
| +5% | +$66.8K | 0.09% | 200 |
|
|
2021
Q3 | $1.02M | Buy |
2,723
+117
| +4% | +$43.6K | 0.07% | 215 |
|
|
2021
Q2 | $995K | Buy |
2,606
+289
| +12% | +$110K | 0.07% | 214 |
|
|
2021
Q1 | $832K | Buy |
2,317
+306
| +15% | +$110K | 0.07% | 221 |
|
|
2020
Q4 | $646K | Buy |
2,011
+152
| +8% | +$48.8K | 0.06% | 238 |
|
|
2020
Q3 | $499K | Sell |
1,859
-14
| -0.7% | -$3.76K | 0.06% | 253 |
|
|
2020
Q2 | $493K | Buy |
1,873
+30
| +2% | +$7.9K | 0.06% | 250 |
|
|
2020
Q1 | $419K | Sell |
1,843
-37
| -2% | -$8.41K | 0.07% | 244 |
|
|
2019
Q4 | $568K | Buy |
1,880
+510
| +37% | +$154K | 0.07% | 262 |
|
|
2019
Q3 | $329K | Sell |
1,370
-347
| -20% | -$83.3K | 0.05% | 334 |
|
|
2019
Q2 | $485K | Buy |
1,717
+280
| +19% | +$79.1K | 0.07% | 242 |
|
|
2019
Q1 | $412K | Buy |
1,437
+550
| +62% | +$158K | 0.07% | 249 |
|
|
2018
Q4 | $233K | Buy |
+887
| New | +$233K | 0.04% | 284 |
|
|
2018
Q1 | – | Sell |
-12,803
| Closed | -$2.88M | – | 262 |
|
|
2017
Q4 | $2.88M | Sell |
12,803
-141
| -1% | -$31.7K | 0.49% | 60 |
|
|
2017
Q3 | $2.46M | Sell |
12,944
-1,756
| -12% | -$333K | 0.46% | 59 |
|
|
2017
Q2 | $2.77M | Sell |
14,700
-1,550
| -10% | -$292K | 0.42% | 58 |
|
|
2017
Q1 | $2.69M | Buy |
16,250
+584
| +4% | +$96.6K | 0.42% | 61 |
|
|
2016
Q4 | $2.25M | Buy |
15,666
+842
| +6% | +$121K | 0.4% | 66 |
|
|
2016
Q3 | $1.86M | Buy |
+14,824
| New | +$1.86M | 0.34% | 76 |
|